Vanguard Personalized Indexing Management
CRBU icon

Vanguard Personalized Indexing Management’s Caribou Biosciences CRBU Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.1K Sell
34,715
-4,518
-12% -$8.93K ﹤0.01% 2116
2026
Q1 		$74.5K Sell
39,233
-2,880
-7% -$4.94K ﹤0.01% 2000
2025
Q4 		$67K Sell
42,113
-73
-0.2% -$153 ﹤0.01% 1852
2025
Q3 		$98.3K Buy
42,186
+1,373
+3% +$2.59K ﹤0.01% 1822
2025
Q2 		$51.4K Buy
40,813
+16,736
+70% +$16.5K ﹤0.01% 1821
2025
Q1 		$22K Buy
24,077
+8,284
+52% +$10.8K ﹤0.01% 1762
2024
Q4 		$25.1K Buy
+15,793
New +$31.8K ﹤0.01% 1752

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Personalized Indexing Management's CRBU Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Caribou Biosciences (CRBU) stake by 12% in Q2 2026, selling an estimated $8.93K and leaving 34,715 shares worth $61.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2116.

Vanguard Personalized Indexing Management first reported a position in CRBU in Q4 2024 and has held it in 7 quarters since. The position peaked at $98.3K in Q3 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Vanguard Personalized Indexing Management held 34,715 shares of Caribou Biosciences worth $61.1K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 4,518 Caribou Biosciences shares in Q2 2026, an estimated $8.93K.
  • Caribou Biosciences made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2116 holding.
  • Vanguard Personalized Indexing Management first reported a position in Caribou Biosciences in Q4 2024 and has held it in 7 quarters since.
  • Vanguard Personalized Indexing Management's Caribou Biosciences position peaked at $98.3K in Q3 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.